Related Experiment Video
Updated: May 5, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Kleine-levin syndrome treated with clarithromycin
Elham Rezvanian1, Nathaniel F Watson
1University of Washington Medicine Sleep Center ; Department of Medicine, Division of Pulmonary and Critical Care, University of Washington.
Kleine-Levin syndrome (KLS) is a rare sleep disorder. This study reports the short-term effectiveness of clarithromycin, offering a potential new treatment avenue for patients experiencing KLS symptoms.
Area of Science:
- Neurology
- Sleep Medicine
Background:
- Kleine-Levin syndrome (KLS) is a rare neurological sleep disorder.
- KLS presents with periodic hypersomnia, cognitive deficits, behavioral changes, hyperphagia, and hypersexuality.
- Current treatments for KLS, including stimulants and mood stabilizers, offer limited efficacy.
Observation:
- A single patient diagnosed with Kleine-Levin syndrome was treated with clarithromycin.
- The short-term effects of clarithromycin on KLS symptoms were observed.
Findings:
- Clarithromycin demonstrated a short-term positive effect in the treated KLS patient.
- This suggests a potential therapeutic role for clarithromycin in managing KLS.
Implications:
- Clarithromycin may represent a novel therapeutic option for Kleine-Levin syndrome.
- Further research is warranted to confirm the efficacy and safety of clarithromycin for KLS treatment.
- Understanding the mechanisms of clarithromycin in KLS could provide insights into the pathophysiology of the disorder.
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Inhibitors of Bacterial DNA Synthesis
Inhibitors of Bacterial Protein Synthesis
Cystic Fibrosis: Management
Sinus disease and chronic...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Clinical Significance of Antibiotic Resistance

